Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-20

Clinical Trial Update: Risk Factors for Residual Neoplasia After Endoscopic Mucosal Resection

View source ↗

Summary

This completed clinical trial examines risk factors for residual neoplasia after endoscopic mucosal resection in colorectal cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vitkovice Hospital | Conditions: Colorectal Cancer | Status: COMPLETED